Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of Bacteroides in the preparation of products for the prevention and treatment of Alzheimer's disease

A technology of Bacteroidetes and Bacteroides dollii, which is applied in the field of Bacteroides applications to achieve the effects of reducing Aβ deposition, improving treatment and prevention effects, and inhibiting Aβ diffusion to the cortex

Active Publication Date: 2022-02-15
CAPITAL UNIVERSITY OF MEDICAL SCIENCES
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In both AD model mice and AD patients, the abundance of Bacteroides has been found to be reduced, but it is closely related to the disease, and the specific strains that increase the abundance can alleviate the disease have not been reported yet

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Bacteroides in the preparation of products for the prevention and treatment of Alzheimer's disease
  • Application of Bacteroides in the preparation of products for the prevention and treatment of Alzheimer's disease
  • Application of Bacteroides in the preparation of products for the prevention and treatment of Alzheimer's disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Embodiment 1, the cultivation of bacteroides

[0039] Bacteroides ovatus (ATCC BAA-1304), Bacteroides vulgatus (ATCC 8482) were purchased from American type culture collection (American type culture collection, ATCC), Bacteroides dorei (DSM 17855) were purchased from the German Culture Collection of Microorganisms (Deutsche Sammlung von Mikroorganismen und Zellkulturen, DSMZ).

[0040] The purchased strains were aseptically inoculated into liquid medium, and then cultured in an anaerobic workstation containing 5% carbon dioxide, 10% hydrogen and 85% nitrogen.

[0041] Among them, the medium formula is shown in Table 1.

[0042] Table 1 Culture medium composition of Bacteroides

[0043]

[0044]

Embodiment 2

[0045] Example 2. Effect of Bacteroides on Aβ Deposition in the Brain of Adult Male Mice

[0046] In this experiment, a kind of Alzheimer’s disease model mouse—5×FAD mouse was used. The 5×FAD mouse was purchased from the Jackson Transgenic Mouse Collection Center; the breeding temperature was 20-24°C, the ambient humidity was 50-60%, and the light was 12 Hours (8:00-20:00), soundproof, food and water ad libitum.

[0047] Six-week-old male 5×FAD transgenic mice were used, and each group of three was randomly divided into experimental group and control group. Firstly, the mice in the experimental group and the control group were treated with antibiotics for two weeks respectively. The specific composition of the antibiotics is shown in Table 2, so as to destroy the intestinal microorganisms in the experimental mice.

[0048] Table 2 Composition of antibiotics used in antibiotic treatment

[0049] components Proportion weight neomycin sulfate 0.5mg / ml Me...

Embodiment 3

[0060] Example 3, Effects of Bacteroides on Aβ Deposition in the Brain of Young Mice

[0061] In this experiment, a kind of Alzheimer’s disease model mouse—5×FAD mouse was used. The 5×FAD mouse was purchased from the Jackson Transgenic Mouse Collection Center; the breeding temperature was 20-24°C, the ambient humidity was 50-60%, and the light was 12 Hours (8:00-20:00), soundproof, food and water ad libitum.

[0062] Male 5×FAD transgenic mice were used. After weaning on the 21st day, antibiotic treatment was started on the 22nd day. The method of gavage was adopted, and the gavage volume was 0.2ml / mouse, once a day, for three consecutive days. The specific antibiotic composition was as follows: Table 2 shows. Every 3 as a group, randomly divided into experimental group and control group.

[0063] From the 25th day, the mice in the experimental group received the active bacterial agent cultured in Example 1 orally. The bacterial liquid needs to be cultured in advance, activa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of application of Bacteroides, and discloses the application of Bacteroides in the preparation of products for preventing and treating Alzheimer's disease. The application of the Bacteroides of the present invention in the preparation of products for the prevention and treatment of Alzheimer's disease, the Bacteroides include Bacteroides ovale, Bacteroides multirdii, and / or Bacteroides vulgaris; can effectively inhibit Alzheimer's disease model animals β‑amyloid deposition in the brain.

Description

technical field [0001] The invention relates to the technical field of Bacteroides application, in particular to the application of a Bacteroides in the preparation of products for preventing and treating Alzheimer's disease. Background technique [0002] Alzheimer's disease (AD) is a degenerative disease of the central nervous system common in middle-aged and elderly people, and it is also the most common type of senile dementia. The main pathological features of AD are extracellular β-amyloid (Aβ) deposition, intracellular phosphorylated tau protein aggregation to form neurofibrillary tangles and global brain atrophy. The main clinical manifestations are progressive loss of cognition, memory, thinking, language ability and behavioral changes. At present, there are more than 52 million AD patients in the world, and there are 10 million AD patients in my country. It is estimated that by 2050, the number of AD patients in the world will exceed 100 million, and the number of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N1/20A61K35/741A61P25/28A23L33/135A23L2/52
CPCA61K35/741A61P25/28A23L33/135A23L2/52A23V2002/00A23V2400/11A23V2400/175A23V2400/113A23V2400/51A23V2200/322A23V2250/284A23V2250/5062
Inventor 张晨刘希成王伟魏梦萍查旭
Owner CAPITAL UNIVERSITY OF MEDICAL SCIENCES